Albin (jim) Nelson

Jim Nelson is a registered patent attorney, a senior shareholder (partner) of Schwegman, Lundberg & Woessner and has over 38 years of experience in the intellectual property field. Dr. Nelson's practice focuses on IP prep and pros., counseling, opinions and adversarial practice in chemical, polymer, pharmaceutical, biotechnology and medical device fields with a special emphasis on counseling and IP work for start-up companies, launching such efforts, development of start-up portfolio assets. Dr. Nelson also handles generic and branded pharmaceutical and biotech IP and adversarial activities especially for Hatch-Waxman service including Paragraph IV opinions and detailed statements, litigation counseling, and associated FDA work. Dr. Nelson has vast experience handling start-up company issues and IP portfolio development for the pharmaceutical, chemical, polymer, paint and biotechnology industries throughout the United States, Canada, Europe and India. He also handles complex infringement and validity opinions and litigation matters as well as such IP prosecution issues as reissue, interpartes review and ex parte reexamination matters. Dr. Nelson has presented seminars on IP prosecution, opinion and litigation practice at pharmaceutical and chemical conferences and intellectual property organizations and associations throughout the world. Dr. Nelson received his B.S. honors in chemistry, cum laude, University of Iowa (1968), his Ph.D. in organic chemistry from the Iowa State University (1972, NASA Fellow, Phi Kappa Phi) and his J.D. from Fordham University (1980; Fordham Law Review). Dr. Nelson is a member of the State Bars of Minnesota and New York (1989, 1980), the U.S. Patent Bar (1976), and the Federal Bar (Minnesota, 1994). Dr. Nelson practiced IP law with organizations in New York from 1976 to 1989 (Pfizer and Kenyon & Kenyon) and in Minnesota (Merchant & Gould, January 1989-1999, partner and director of IP prep and pros group). Dr. Nelson joined SLW IP in 1999.